Max Warncke
Impact in
- Immunology top 10%
- IL-33, ST2, and ILC Pathways
- T-cell and B-cell Immunology
- Immunotoxicology and immune responses
- Immunotherapy and Immune Responses
- Nephrology top 10%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
Papers in
-
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 3
- IL-33, ST2, and ILC Pathways 1
-
- Acute Kidney Injury Research 2
- Renal Diseases and Glomerulopathies 1
- Chronic Kidney Disease and Diabetes 1
- Co-authors
- Frank Kolbinger (2 shared papers)Christoph Heusser (2 shared papers)Thomas Calzascia (1 shared paper)Michele Coulot (1 shared paper)Annick Waldt (1 shared paper)Martin Beibel (1 shared paper)Rachel Cuttat (1 shared paper)Kea Martin (1 shared paper)
- Journals
- Blood (2 papers)JCI Insight (1 paper)American Journal of Transplantation (1 paper)Kidney International Reports (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- SwitzerlandGermanyNetherlands
In The Last Decade
Max Warncke
11 papers receiving 529 citations
Peers
Comparison fields: 5 of 50
- Immunology 179
- Nephrology 80
- Hematology 87
- Transplantation 17
- Radiology, Nuclear Medicine and Imaging 82
Countries citing papers authored by Max Warncke
This map shows the geographic impact of Max Warncke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Warncke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Warncke more than expected).
Fields of papers citing papers by Max Warncke
This network shows the impact of papers produced by Max Warncke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Warncke. The network helps show where Max Warncke may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Warncke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 146 | |
| 2 | 2020 | 130 | |
| 3 | 2012 | 92 | |
| 4 | 2018 | 79 | |
| 5 | 2012 | 40 | |
| 6 | 2005 | 17 | |
| 7 | 2010 | 14 | |
| 8 | 2024 | 14 | |
| 9 | 2009 | 5 | |
| 10 | 2004 | 4 | |
| 11 | 2006 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2026 | 0 |
About Max Warncke
Max Warncke is a scholar working on Immunology, Nephrology, Radiology, Nuclear Medicine and Imaging, Genetics and Molecular Biology, having authored 13 papers that have together received 542 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immunotherapy and Immune Responses (3 papers), Acute Kidney Injury Research (2 papers), Renal Diseases and Glomerulopathies (1 paper), IL-33, ST2, and ILC Pathways (1 paper), Virus-based gene therapy research (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Immunology (179 citations), Nephrology (80 citations), Hematology (87 citations), Transplantation (17 citations) and Radiology, Nuclear Medicine and Imaging (82 citations). Max Warncke has collaborated with scholars based in Switzerland, Germany and Netherlands. Frequent co-authors include Frank Kolbinger, Christoph Heusser, Thomas Calzascia, Michele Coulot, Annick Waldt, Martin Beibel, Rachel Cuttat, Kea Martin, Ulrike Naumann and Grazyna Wieczorek. Their work appears in journals such as Blood, JCI Insight, American Journal of Transplantation, Kidney International Reports and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.